Physician profile
Jason D Wright
NPI 1811941792
$19,217.62
in general payments reported to CMS, 2019-2025
18 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,666 · 2020: $2,400 · 2021: $23.05 · 2022: $37.23 · 2023: $915 · 2024: $8,029 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,715 · Travel and Lodging: $859 · Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,715.00 |
| Travel and Lodging | $859.10 |
| Food and Beverage | $516.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $8,164.10 | 2022-2025 | Jemperli, Zejula |
| Clovis Oncology, INC. | $7,200.05 | 2019 | |
| Eisai INC. | $2,424.72 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $928.36 | 2019-2023 | |
| F. Hoffmann-La Roche Ag | $370.78 | 2019 | |
| Tesaro, INC. | $44.71 | 2019 | |
| Solventum Corporation | $24.49 | 2025 | Kerramax Care, Activ.A.C., Promogran Prisma |
| Myriad Genetic Laboratories, INC. | $23.05 | 2021 | |
| Kyowa Kirin, INC. | $22.16 | 2019 | |
| Amgen INC. | $15.20 | 2019 |
8 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.